Literature DB >> 2844515

Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus.

T Horigome1, F Ogata, T S Golding, K S Korach.   

Abstract

Increased proteolytic degradation of the estrogen receptor (ER) was detected in uterine cytosol of estradiol-treated ovariectomized mice compared to saline controls. Estradiol had no direct effect on the proteinase activity or susceptibility of the ER to the enzyme. The proteolytic activity gradually increased after a single injection of estradiol with early increases at 2 and 8 h followed by a progressive increase which reached a maximum at 36 h. The proteinase(s) activity resulted in cleavage of the native ER form of 65,000 (65 K ER) to a product of limited proteolysis having an apparent molecular weight of 54,000 (54 K ER). The pH optimum for this proteinase activity was 6.0. The proteinase was inhibited by 2.5 mM p-chloromercuribenzoic acid and 2.5 mM p-chloromercuriphenylsulfonate and partially inhibited by 2.5 mM iodoacetamide but not by 1 mg/ml leupeptin, 0.1 mg/ml antipain, 0.1 mg/ml chymostatin, 0.1 mg/ml pepstatin, 0.1 mg/ml E-64, 2.5 mg/ml soybean trypsin inhibitor, 2.5 mM phenylmethylsulfonylfluoride, 2.5 mM diisopropylfluorophosphate, and 10 mM EGTA. The results suggested that the proteinase(s) had a thiol group essential for its activity. Estrogen receptor in the mouse uterine cytosol fraction appears to be degraded sequentially in two steps in which 65 K ER is cleaved to a 54 K ER which upon longer incubation is further degraded to a 37 K form. The second step was inhibited by leupeptin, antipain, chymostatin, E-64, and p-chloromercuribenzoic acid. A possible function of the 54 K ER under physiological conditions is discussed since the 54 K ER was also found in nuclear samples. This form of the ER still retains the ability to bind estradiol and DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844515     DOI: 10.1210/endo-123-5-2540

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Estrogen-induced synthesis of uterine proteins declines during aging.

Authors:  M K Thakur; J Kaur
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

Review 2.  Disentangling the molecular mechanisms of action of endogenous and environmental estrogens.

Authors:  Angel Nadal; Paloma Alonso-Magdalena; Cristina Ripoll; Esther Fuentes
Journal:  Pflugers Arch       Date:  2004-10-29       Impact factor: 3.657

3.  Analysis in vitro of uterine estrogen receptor conformation of young and old rats.

Authors:  M K Tnakur; J Kaur
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

Review 4.  Evolving trends in steroid hormone receptor research.

Authors:  M K Agarwal
Journal:  Naturwissenschaften       Date:  1990-04

Review 5.  Cell-specific mechanisms of estrogen receptor in the pituitary gland.

Authors:  F Demay; S Geffroy; C Tiffoche; M de Monti; M L Thieulant
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

6.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

Authors:  D M Ignar-Trowbridge; K G Nelson; M C Bidwell; S W Curtis; T F Washburn; J A McLachlan; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Authors:  S Trivedi; M Piccart; C Muquardt; N Gilot; S Hadiy; D Patel; G Leclercq
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Authors:  S A Fuqua; D C Allred; R M Elledge; S L Krieg; M G Benedix; Z Nawaz; B W O'Malley; G L Greene; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Truncated forms of DNA-binding estrogen receptors in human breast cancer.

Authors:  G K Scott; P Kushner; J L Vigne; C C Benz
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression.

Authors:  Jun Sun; Wen Zhou; Kosalai Kaliappan; Zafar Nawaz; Joyce M Slingerland
Journal:  Mol Endocrinol       Date:  2012-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.